Nature Medicine · 13 July 2026 · From issue 08
A new targeted drug shrank tumors in many patients with an aggressive, spreading eye cancer.
Matteo S. Carlino, Ellen Kapiteijn et al., An anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial, Nature Medicine.
Integrity screen: passed (3 checks) Checked 17 August 2026. Read the source
The plain-language reading of this paper is in the full issue, for subscribers.
Read the full issue